Etienne Hoffer, Charles Pirlet, Pierre Troisfontaines
Department of Cardiology, CHR Citadelle Hospital, Liège, Belgium.
Ann Med Surg (Lond). 2022 Jun;78:103694. doi: 10.1016/j.amsu.2022.103694. Epub 2022 Apr 29.
Cardiovascular disorders have been extensively reported during COVID-19 illness, including arrhythmias such as atrioventricular conduction disturbances. To date, one case of transient heart block has been reported after COVID-19 vaccine.
A 73 years-old woman presented with shortness of breath and fatigue 2 weeks after receiving her second dose of BNT162b2 SARS-CoV-2 mRNA vaccine. ECG showed complete AV block with normal narrow QRS complexes. Chronic treatment with Bisoprolol for hypertension was stopped but complete AV block persisted 48 hours thereafter. Therefore, a permanent pacemaker was implanted. Three months later, pacemaker follow-up revealed no ventricular stimulation, suggesting complete recovery of AV conduction, even after resumption of bisoprolol. Five months after the second dose, she received a third dose of the same vaccine. Three weeks later, she once again complained of dyspnea on exertion. ECG showed sinus rhythm with permanent ventricular stimulation. After device inhibition, complete AV block was confirmed and, 2 weeks later, conduction was restored once more.
It is known that vaccines can induce AV conduction disturbances, mostly reversible. The underlying mechanisms leading to high-degree AV block remain unclear and are probably multiple. Although being exceptional after COVID-19 vaccine, our case illustrates the fact that the latter can induce such a disturbance which may be transient and recurrent even in the absence of underlying conduction disorder.
COVID-19 vaccination may transitorily interfere with cardiac conduction system even in subjects without known underlying heart disease.
在新型冠状病毒肺炎(COVID-19)疾病期间,心血管疾病已被广泛报道,包括心律失常,如房室传导障碍。迄今为止,已有1例COVID-19疫苗接种后出现短暂性心脏传导阻滞的病例报道。
一名73岁女性在接种第二剂BNT162b2严重急性呼吸综合征冠状病毒2(SARS-CoV-2)信使核糖核酸(mRNA)疫苗2周后出现呼吸急促和疲劳。心电图显示完全性房室传导阻滞,QRS波群正常且狭窄。因高血压长期服用比索洛尔的治疗被停用,但此后48小时完全性房室传导阻滞仍持续存在。因此,植入了永久性起搏器。3个月后,起搏器随访显示无心室刺激,提示即使在重新服用比索洛尔后,房室传导也已完全恢复。在接种第二剂疫苗5个月后,她接种了第三剂相同疫苗。3周后,她再次抱怨运动时呼吸困难。心电图显示窦性心律伴永久性心室刺激。在设备抑制后,确认存在完全性房室传导阻滞,2周后传导再次恢复。
已知疫苗可诱发房室传导障碍,多数为可逆性。导致高度房室传导阻滞的潜在机制尚不清楚,可能是多因素的。尽管在COVID-19疫苗接种后这种情况较为罕见,但我们的病例表明,即使在没有潜在传导障碍的情况下,COVID-19疫苗也可诱发这种可能短暂且复发的障碍。
即使在没有已知潜在心脏病的受试者中,COVID-19疫苗接种也可能暂时干扰心脏传导系统。